Brucellosis in Cattle: Modern Serological and Molecular Diagnosis

Introduction

Bovine brucellosis is a chronic infectious disease of cattle caused primarily by Brucella abortus, a Gram-negative facultative intracellular coccobacillus. The disease is characterized by reproductive failure, including abortion in the last trimester of gestation, retained placenta, orchitis in bulls, and reduced milk yield. Beyond its economic impact on livestock production, B. abortus is a zoonotic pathogen capable of causing undulant fever, arthritis, and endocarditis in humans through direct contact with infected animals or consumption of unpasteurized dairy products [1, 2, 3]. The global burden of brucellosis remains substantial, with endemic foci persisting in regions of Africa, Asia, the Middle East, and parts of Latin America [4, 5, 6]. Eradication programs rely on accurate diagnostic tools to identify infected animals, inform culling decisions, and monitor vaccination efficacy. This review examines the biophysical principles, operational characteristics, and interpretive frameworks of modern serological and molecular assays used in bovine brucellosis diagnosis, with emphasis on the Rose Bengal test (RBT), enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), and their integration into surveillance systems.

Pathogen Biology and Host Interaction

Brucella abortus possesses a lipopolysaccharide (LPS) outer membrane that is the primary target of serological assays. The O-polysaccharide chain of smooth LPS elicits a strong antibody response, predominantly of the immunoglobulin G (IgG) and immunoglobulin M (IgM) classes, following infection. The bacterium survives and replicates within host macrophages by inhibiting phagolysosome fusion and modulating the host immune response [7]. Chronic infection leads to persistent bacteremia and shedding in milk, vaginal discharges, and fetal tissues. The incubation period ranges from two weeks to several months, and latent infections can reactivate during pregnancy. Strain diversity, as revealed by whole-genome phylogenetic analysis, influences virulence and host adaptation [7, 8]. For example, B. abortus strains isolated from sheep, yak, and cattle in Qinghai, China, exhibit distinct genomic signatures that may affect diagnostic target selection [7]. Understanding these molecular variations is critical for designing assays that maintain sensitivity across circulating strains.

Serological Diagnosis

Serological methods detect antibodies against Brucella LPS and are the cornerstone of herd-level screening. The choice of assay depends on the epidemiological context, vaccination status, and required throughput.

Rose Bengal Test (RBT)

The RBT is a rapid, inexpensive agglutination test used for initial screening. It employs a stained B. abortus antigen (killed whole cells) at pH 3.6 to 3.8, which preferentially detects IgM and IgG antibodies. A positive reaction is indicated by visible agglutination within four minutes. The test has high sensitivity (approximately 95%) but moderate specificity, particularly in vaccinated herds where antibodies from strain 19 or RB51 vaccines can cause false positives [8]. The RBT is recommended by the World Organisation for Animal Health (WOAH) as a prescribed test for international trade. Its simplicity makes it suitable for field use, but confirmatory testing with ELISA or complement fixation is required for positive samples.

Enzyme-Linked Immunosorbent Assay (ELISA)

Indirect ELISA (iELISA) and competitive ELISA (cELISA) are the most widely used serological confirmatory methods. iELISA uses purified smooth LPS coated on microtiter plates; bound antibodies are detected with an anti-bovine IgG conjugate. cELISA employs a monoclonal antibody that competes with serum antibodies for LPS epitopes, reducing cross-reactivity with Yersinia enterocolitica O:9 and other Gram-negative bacteria. The sensitivity and specificity of commercial ELISA kits exceed 98% in non-vaccinated populations [1, 9]. The assay can be automated for high-throughput testing in centralized laboratories. A variant, the milk ELISA, detects antibodies in bulk tank or individual cow milk samples, enabling non-invasive surveillance [9]. The milk ring test (MRT), a simple agglutination test using stained Brucella antigen in milk, is used for herd-level screening in dairy operations. The MRT relies on the binding of antibodies to fat globules; a positive result is indicated by a colored cream layer. However, the MRT has lower sensitivity than milk ELISA and is affected by milk composition and storage conditions.

Comparative Performance of Serological Assays

Molecular Diagnosis

Molecular methods detect Brucella nucleic acids directly from clinical samples, offering high sensitivity and the ability to differentiate species and strains. These assays are particularly valuable for confirming infection in serologically ambiguous cases, detecting early-stage infection before seroconversion, and identifying the pathogen in aborted fetal tissues.

Conventional and Real-Time PCR

Target genes for PCR include bcsp31 (encoding a 31-kDa immunogenic protein), IS711 (insertion sequence), and omp25 (outer membrane protein). Conventional PCR with agarose gel electrophoresis provides qualitative detection, while real-time PCR (qPCR) using hydrolysis probes (e.g., TaqMan) enables quantification and higher throughput. A triplex TaqMan qPCR assay has been developed for simultaneous detection of Brucella spp., bovine viral diarrhea virus (BVDV), and Pasteurella multocida in cattle, facilitating differential diagnosis of reproductive pathogens [10]. The analytical sensitivity of qPCR for Brucella in milk and tissue samples is approximately 10-100 colony-forming units per reaction. DNA extraction from milk, vaginal swabs, or fetal stomach contents is optimized using commercial kits with bead-beating steps to lyse the tough cell wall of Brucella.

Multiplex and High-Resolution Approaches

Multiplex PCR panels can differentiate B. abortus, B. melitensis, and B. suis based on species-specific polymorphisms in the omp2 locus or the IS711 copy number. High-resolution melting (HRM) analysis after PCR allows rapid genotyping without sequencing. Whole-genome sequencing (WGS) provides the highest resolution for epidemiological tracing and identification of virulence markers [7, 8]. WGS has been used to map the spread of B. abortus strains in industrial dairy herds and to assess the impact of vaccination on strain diversity [8]. The cost and bioinformatics expertise required for WGS currently limit its use to reference laboratories and outbreak investigations.

Novel Diagnostic Platforms

Quantum dot microspheres (QDMs) conjugated with Brucella LPS have been used in immunochromatographic strip assays for rapid detection of antibodies in serum and milk [9]. This technology combines the sensitivity of fluorescence with the simplicity of lateral flow, achieving limits of detection comparable to ELISA in under 15 minutes. Another emerging approach is the identification of DIVA (Differentiating Infected from Vaccinated Animals) antigens using quantitative proteomics. The transcriptional regulator GntR has been proposed as a novel DIVA antigen that distinguishes naturally infected cattle from those vaccinated with RB51 [11]. Such antigens could be incorporated into future serological or molecular assays to improve specificity in vaccinated populations.

Surveillance and Eradication Programs

Effective control of bovine brucellosis requires integrated surveillance combining serological screening, molecular confirmation, and risk-based sampling. The diagnostic workflow typically proceeds from herd-level screening (RBT or MRT) to individual animal confirmation (ELISA or qPCR) and finally to strain characterization (PCR typing or WGS) for epidemiological purposes.

flowchart TD
    A[Herd-level screening], > B{RBT or MRT positive?}
    B, >|Yes| C[Individual animal ELISA]
    B, >|No| D[Continue routine surveillance]
    C, > E{ELISA positive?}
    E, >|Yes| F[Confirm with qPCR on milk or tissue]
    E, >|No| G[Consider false positive; retest in 30 days]
    F, > H{Strain typing needed?}
    H, >|Yes| I[Multiplex PCR or WGS]
    H, >|No| J[Report and cull positive animal]
    I, > J
    J, > K[Enhanced surveillance in herd]
    K, > L[Repeat screening after 60 days]

Spatial epidemiology and socio-economic factors influence brucellosis prevalence. In Sri Lanka, for example, herd-level risk factors include large herd size, introduction of new animals without testing, and proximity to wildlife reservoirs [5]. Geographically weighted regression models have identified local clusters of high seroprevalence in China, guiding targeted interventions [4]. In Bangladesh, a 25-year meta-analysis revealed a stable but high prevalence in cattle, with seasonal peaks linked to calving patterns [2]. Vaccination with live attenuated strains (S19 or RB51) reduces shedding and abortion but complicates serological interpretation. The use of DIVA-compatible vaccines and companion diagnostic tests is essential for distinguishing infected from vaccinated animals [11].

Zoonotic risk is a major driver of surveillance efforts. Human brucellosis cases often correlate with animal seroprevalence, as demonstrated in northern Kenya [12] and Algeria [6]. Simulation models predict that reducing bovine brucellosis by 50% could decrease human incidence by a similar proportion [13]. Therefore, veterinary diagnostic programs are integral to one health strategies. Farmer resilience and compliance with testing protocols are critical for program success; studies in Belgium indicate that trust in veterinary authorities and perceived economic benefits influence participation [14].

Conclusion

Modern diagnosis of bovine brucellosis relies on a tiered approach combining rapid serological screening with highly specific molecular confirmation. The Rose Bengal test and milk ring test remain valuable for field use, while ELISA and real-time PCR provide the accuracy needed for eradication programs. Emerging technologies such as quantum dot immunochromatography and proteomics-based DIVA antigens promise to further improve diagnostic performance. Integration of spatial epidemiology, genomic surveillance, and one health frameworks will enhance the effectiveness of control measures. Continued investment in diagnostic infrastructure and farmer engagement is essential to reduce the global burden of this zoonotic disease.

References

[1] Yang Q, Zhang N, Shi Y, et al. Spatiotemporal dynamics and serosurveillance landscape of brucellosis at the human-animal interface in the Chinese Southwest: A retrospective study. PLoS Negl Trop Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42213764/

[2] Raquib R, Arnob FA, Hossain R, et al. Prevalence, Associated Factors, and Temporal Trends of Brucella Detection Across Human and Animal Hosts in Bangladesh: A 25-Year Meta-Analysis. Vet Med Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42206877/

[3] Kuhn C, Radon K, Pérez Morales FM, et al. Human-animal contact and zoonotic exposure from wild and domestic animals: A cross-sectional study in wildlife-rich areas of Bolivia, Chile, and Guatemala. One Health. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42183050/

[4] Tian Z, Dong Y, Yuan P, et al. From Global to Local: A Multiscale Geographically Weighted Regression Analysis of Bovine Brucellosis Risk Factors. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42253324/

[5] Sugino Y, Vaseeharan S, Kothalawala KACHA, et al. Spatial epidemiology and socio-economics of bovine brucellosis in selected districts of the Northern Province of Sri Lanka. J Vet Med Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42236214/

[6] Ghougal K, Azizi A, Laib S, et al. Epidemiological trends and animal-human relationships of brucellosis in Algeria from 2010 to 2022: A one health approach. Comp Immunol Microbiol Infect Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42114331/

[7] Cao X, Yang Q, Xue H, et al. Identification and Genome Phylogenetic Analysis of Three Brucella abortus Strains From Sheep, Yak, and Cow in Qinghai, China. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42253325/

[8] Alamian S, Amiry K, Bahreinipour A, et al. Epidemiological Trends and Strain Distribution of Bovine Brucellosis in Vaccinated Industrial Dairy Cattle (2021-2024). Vet Med Int. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42148180/

[9] Chen M, Yan X, Zhao J, et al. Detection of Bovine Brucellosis Antibodies in Serum and Milk Using Quantum Dot Microspheres Immunochromatographic Assay. Microorganisms. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42197446/

[10] Hu J, Zhou W, Liang S, et al. Epidemiological surveillance of BVDV, Pasteurella multocida, and Brucella spp. infections in cattle from Guizhou, China using a newly established triplex TaqMan qPCR assay. Vet Res Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42113298/

[11] Lv H, Liu X, Luo Y, et al. Quantitative proteomics identifies GntR as a novel potential DIVA antigen for bovine brucellosis. Appl Microbiol Biotechnol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42168698/

[12] Mwatondo A, Muturi M, Akoko JM, et al. Seroincidence of Brucella spp. infection among humans and livestock in Northern Kenya. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42178341/

[13] Lou P, Huang Y, Fan X, et al. Simulation and prediction of human brucellosis epidemic trends in Changji city. Infect Dis Model. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42211554/

[14] Renault V, Delooz L, Humblet MF, et al. Resilience of Belgian Cattle Farmers Towards Infectious Diseases Outbreaks. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42111054/

[15] Ansabayeva L, Nurgaliyev B, Darmenova A, et al. Veterinary-sanitary evaluation and biochemical quality of beef from cattle with chronic infectious diseases: Impact of chronic brucellosis on nutritional composition. Vet World. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42245466/